查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1559676

全球肠道疾病检测市场

Enteric Disease Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 158 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球肠道疾病检测市场将达到 31 亿美元

2023年全球肠道疾病检测市场估计为22亿美元，预计到2030年将达到31亿美元，2023年至2030年复合年增长率为4.8%。细菌性肠道疾病检测是本报告分析的细分市场之一，预计复合年增长率为 4.8%，到分析期结束时将达到 18 亿美元。分析期间，寄生虫肠道疾病测试领域的复合年增长率预计为4.1%。

美国市场预估达5.872亿美元，中国预计复合年增长率为7.1%

2023年美国肠道疾病检测市场预计将达到5.872亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 6.575 亿美元，2023-2030 年分析期间复合年增长率为 7.1%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.6% 和 4.4%。在欧洲，德国的复合年增长率预计为 2.7%。

全球肠道疾病检测市场—主要趋势与驱动因素总结

肠道疾病检测如何彻底改变公共卫生和疾病控制？

肠道疾病检测为诊断影响胃肠道的感染疾病提供快速、准确和全面的工具，正在彻底改变公共卫生和疾病控制。由细菌、病毒和寄生虫引起的肠道疾病是世界各地的一个主要健康问题，特别是在清洁水和卫生设施有限的地区。这些疾病会导致严重脱水、营养不良，甚至死亡，尤其是儿童和老年人等弱势族群。快速且准确诊断肠道感染疾病的能力对于有效治疗、遏制和预防疫情至关重要。现代肠道疾病检测利用先进的诊断技术，如分子测定、免疫测量和次世代定序，以高灵敏度和特异性检测多种病原体。透过使医疗保健提供者能够快速确定胃肠道症状的确切原因，肠道疾病检测可以改善患者的治疗结果，减少感染疾病的传播，并帮助控制和预防全球范围内的肠道倡议。

哪些创新正在改善肠道疾病检测？

肠道疾病检测的创新正在透过分子诊断、就地检验和多重检测平台的进步来增强其功能。最重要的进步之一是聚合酵素链锁反应（PCR）和其他核酸扩增技术的使用。这些分子诊断方法可以在数小时内识别粪便检体中的特定细菌、病毒和寄生虫。分子诊断的速度和准确性对于控制集体爆发和确保患者快速接受适当的治疗、降低併发症和传播的风险特别有用。

即时检测 (POCT) 也是正在改变肠道疾病诊断的重要创新。 POCT 测试设备设计用于床边或远端位置，无需专门的测试设备即可提供即时结果。这种可携式、易于使用的设备在传统测试基础设施不便、资源有限的地区尤其有用。 POCT能够在现场快速诊断和治疗肠道疾病，缩短治疗时间并改善预后。这项创新在疫情爆发的情况下也很重要，及时辨识致病病原体可以防止疾病传播。

多重检测平台是肠道疾病检测的另一项重大进展。这些系统可以从一份样本同时检测多种病原体，从而可以全面分析胃肠道症状的潜在原因。多重检测在症状可能由多种病原体引起的情况下特别有用，例如食物中毒爆发或免疫力缺乏的患者。透过提供广泛的诊断工具，多重测试减少了对多次单独测试的需求，节省了时间和资源，同时允许对患者的病情进行彻底的调查。

这些创新使肠道疾病检测更快、更准确、更容易获得，对于有效的疾病控制和公共卫生保护至关重要。

肠道疾病检测如何影响公众健康和患者的治疗结果？

肠道疾病检测能够及时诊断、治疗和预防影响消化器官系统的感染疾病，对公共卫生和患者治疗结果有重大影响。对于个别患者来说，准确、快速的检测对于识别导致疾病的特定病原体并指南适当的治疗至关重要。如果没有正确的诊断，患者可能会接受无效或不适当的治疗，导致长期患病、增加併发症的风险并增加医疗费用。肠道疾病检测可以进行有针对性的治疗，缩短疾病的持续时间和严重程度，并最大程度地减少脱水等併发症的可能性，特别是对于儿童和老年人等弱势群体。

从公共卫生的角度来看，肠道疾病检测对于减少感染疾病的传播至关重要。快速识别社区中的感染疾病病原体使公共卫生当局能够更有效地实施遏制措施，例如隔离感染者、警告公众和追踪污染源。在食物中毒的情况下，快速检测可以识别受污染的食品，防止进一步感染并保护公众健康。此外，肠道疾病检测产生的资料还可以有助于监测工作，帮助追踪疾病趋势、监测新出现的病原体并评估公共卫生干预措施的有效性。

肠道疾病检测在全球健康中也发挥着重要作用，特别是在胃肠道感染疾病负担较高的地区。在清洁水和卫生设施有限的地区，肠道疾病是发病和死亡的主要原因。透过提供早期检测和治疗所需的工具，肠道疾病检测支持更广泛的努力，以减轻这些疾病的负担并改善弱势群体的健康。此外，在难民营等人道环境中，提供快速、准确的检测至关重要。在那里，肠道疾病的流行可以迅速传播并造成毁灭性后果。

整体而言，肠道疾病检测对公共卫生的影响是深远的，可以改善患者的治疗结果，加强疾病控制工作，并有助于预防未来的疫情爆发。

推动肠道疾病检测市场成长的趋势是什么？

多种趋势正在推动肠道疾病检测市场的成长，包括食物中毒发生率的增加、诊断技术的进步、对快速检测解决方案的需求不断增长以及旨在控制感染疾病的全球公共卫生努力。食源性疾病发生率的增加是推动肠道疾病检测需求的关键因素。随着食品供应链日益全球化，受污染食品造成大规模疫情爆发的风险增加，人们更加重视食品安全并快速识别此类疫情，因此越来越需要可靠的遏制和遏制检测方法。

诊断技术尤其是分子诊断技术的进步也促进了肠道疾病检测市场的成长。更快、更准确和更具成本效益的诊断工具的开发扩大了肠道疾病检测的可用性和可近性。基于 PCR 的检测、次世代定序和多重平台等创新使得即使在资源匮乏的环境中也能够以高灵敏度和特异性同时检测多种病原体。这些进步不仅改善了患者护理，还透过为监测和疫情应对提供基本资料来支持更广泛的公共卫生工作。

对快速测试解决方案的需求不断增长也是推动市场成长的关键趋势。在临床和公共卫生环境中，对能够提供快速结果以实现快速治疗和介入的诊断测试的需求不断增长。这种需求在感染疾病爆发和自然灾害等紧急情况下尤其明显，及时诊断对于防止疾病传播和拯救生命至关重要。现场护理测试设备的开发和部署可以在现场提供快速、准确的结果，从而满足了这一需求并促进了在各种环境中的采用。

旨在减轻肠道疾病负担的全球公共卫生倡议，特别是在低收入和中等收入国家，也正在推动肠道疾病检测市场的成长。世界卫生组织 (WHO) 和疾病管制与预防中心 (CDC) 等组织正在投资改善诊断服务、加强疾病监测系统并增强快速应对疫情爆发的能力的计画。这些努力推动了对支持这些目标的先进肠道疾病检测解决方案的需求。

此外，对抗菌素抗药性 (AMR) 的关注正在影响肠道疾病检测市场。随着人们对抗生素滥用和抗药性病原体增加的担忧日益增加，人们越来越重视准确诊断以确保适当的治疗。能够快速识别致病病原体及其抗药性的肠道疾病检测对于对抗抗菌素抗药性至关重要。

这些趋势凸显了肠道疾病检测在改善公共卫生、加强疾病控制和应对感染疾病挑战方面的重要作用。为了使肠道疾病检测继续成为全球医疗保健的重要组成部分，检测技术的创新和全球健康的倡议将成为市场进一步成长和开拓的驱动力。

受访企业范例（共12家）

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia（CIDRZ）
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP11810

Global Enteric Disease Testing Market to Reach US$3.1 Billion by 2030

The global market for Enteric Disease Testing estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.1 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Bacterial Enteric Disease Testing, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Parasitic Enteric Disease Testing segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$587.2 Million While China is Forecast to Grow at 7.1% CAGR

The Enteric Disease Testing market in the U.S. is estimated at US$587.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$657.5 Million by the year 2030 trailing a CAGR of 7.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Enteric Disease Testing Market - Key Trends and Drivers Summarized

How Is Enteric Disease Testing Revolutionizing Public Health and Disease Management?

Enteric disease testing is revolutionizing public health and disease management by providing rapid, accurate, and comprehensive tools for diagnosing infections that affect the gastrointestinal tract. Enteric diseases, caused by bacteria, viruses, or parasites, are a significant global health concern, particularly in areas with limited access to clean water and sanitation. These diseases can lead to severe dehydration, malnutrition, and, in some cases, death, especially among vulnerable populations such as children and the elderly. The ability to quickly and accurately diagnose enteric infections is critical for effective treatment, containment, and prevention of outbreaks. Modern enteric disease testing leverages advanced diagnostic technologies, including molecular assays, immunoassays, and next-generation sequencing, to detect a wide range of pathogens with high sensitivity and specificity. By enabling healthcare providers to identify the exact cause of gastrointestinal symptoms promptly, enteric disease testing is improving patient outcomes, reducing the spread of infections, and supporting public health initiatives aimed at controlling and preventing enteric diseases worldwide.

What Innovations Are Enhancing the Functionality of Enteric Disease Testing?

Innovations in enteric disease testing are enhancing its functionality through advancements in molecular diagnostics, point-of-care testing, and multiplex testing platforms. One of the most significant developments is the use of polymerase chain reaction (PCR) and other nucleic acid amplification techniques, which allow for the rapid detection of genetic material from pathogens with high accuracy. These molecular diagnostic methods can identify specific bacteria, viruses, and parasites in stool samples within hours, compared to traditional culture methods that may take days. The speed and precision of molecular diagnostics are particularly valuable in managing outbreaks and ensuring that patients receive the appropriate treatment quickly, thereby reducing the risk of complications and transmission.

Point-of-care testing (POCT) is another key innovation that is transforming enteric disease diagnostics. POCT devices are designed for use at the bedside or in remote settings, providing immediate results without the need for specialized laboratory equipment. These portable, easy-to-use devices are particularly beneficial in resource-limited areas where access to traditional laboratory infrastructure may be lacking. POCT allows for the rapid diagnosis and treatment of enteric diseases in the field, reducing the time to care and improving the chances of a successful outcome. This innovation is also critical in outbreak situations, where timely identification of the causative pathogen can prevent the spread of disease.

Multiplex testing platforms represent another major advancement in enteric disease testing. These systems can simultaneously detect multiple pathogens from a single sample, providing a comprehensive analysis of potential causes of gastrointestinal symptoms. Multiplex tests are particularly useful in cases where symptoms could be caused by a variety of pathogens, such as in foodborne illness outbreaks or in immunocompromised patients. By providing a broad-spectrum diagnostic tool, multiplex testing reduces the need for multiple individual tests, saving time and resources while ensuring a thorough investigation of the patient’s condition.

These innovations are making enteric disease testing more rapid, accurate, and accessible, which is crucial for effective disease management and the protection of public health.

How Does Enteric Disease Testing Impact Public Health and Patient Outcomes?

Enteric disease testing has a profound impact on public health and patient outcomes by enabling the timely diagnosis, treatment, and prevention of infections that affect the gastrointestinal system. For individual patients, accurate and rapid testing is critical for identifying the specific pathogen responsible for their illness, which guides appropriate treatment. Without proper diagnosis, patients may receive ineffective or inappropriate treatments, leading to prolonged illness, increased risk of complications, and higher healthcare costs. Enteric disease testing allows for targeted therapy, reducing the duration and severity of the illness and minimizing the potential for complications such as dehydration, especially in vulnerable populations like children and the elderly.

From a public health perspective, enteric disease testing is essential for controlling the spread of infectious diseases. Rapid identification of pathogens in community outbreaks allows public health authorities to implement containment measures more effectively, such as isolating infected individuals, issuing public warnings, and tracing the source of contamination. In the case of foodborne illnesses, prompt testing can lead to the identification of contaminated food products, preventing further cases and protecting public health. Moreover, the data generated from enteric disease testing contribute to surveillance efforts, helping to track trends in disease incidence, monitor emerging pathogens, and evaluate the effectiveness of public health interventions.

Enteric disease testing also plays a vital role in global health, particularly in regions with high burdens of gastrointestinal infections. In areas where access to clean water and sanitation is limited, enteric diseases are a leading cause of morbidity and mortality. By providing the tools needed for early detection and treatment, enteric disease testing helps to reduce the burden of these diseases and supports broader efforts to improve health outcomes in vulnerable populations. Additionally, the availability of rapid and accurate testing is crucial in humanitarian settings, such as refugee camps, where outbreaks of enteric diseases can spread quickly and have devastating consequences.

Overall, the impact of enteric disease testing on public health is far-reaching, improving patient outcomes, enhancing disease control efforts, and contributing to the prevention of future outbreaks.

What Trends Are Driving Growth in the Enteric Disease Testing Market?

Several trends are driving growth in the enteric disease testing market, including the increasing incidence of foodborne illnesses, advancements in diagnostic technology, the rising demand for rapid testing solutions, and global public health initiatives aimed at controlling infectious diseases. The growing incidence of foodborne illnesses is a significant factor fueling the demand for enteric disease testing. As globalization of the food supply chain increases, the risk of widespread outbreaks caused by contaminated food products has risen, prompting greater emphasis on food safety and the need for reliable testing methods to quickly identify and contain such outbreaks.

Advancements in diagnostic technology, particularly in molecular diagnostics, are also contributing to the growth of the enteric disease testing market. The development of faster, more accurate, and cost-effective diagnostic tools has expanded the availability and accessibility of enteric disease testing. Innovations such as PCR-based assays, next-generation sequencing, and multiplex platforms have made it possible to detect multiple pathogens simultaneously with high sensitivity and specificity, even in low-resource settings. These advancements are not only improving patient care but also supporting broader public health efforts by providing essential data for surveillance and outbreak response.

The rising demand for rapid testing solutions is another key trend driving market growth. In both clinical and public health settings, there is a growing need for diagnostic tests that can deliver results quickly, allowing for prompt treatment and intervention. This demand is particularly acute in emergency situations, such as outbreaks or natural disasters, where timely diagnosis is critical to preventing the spread of disease and saving lives. The development and deployment of point-of-care testing devices that provide rapid, accurate results in the field are meeting this need and driving adoption in diverse settings.

Global public health initiatives aimed at reducing the burden of enteric diseases, particularly in low- and middle-income countries, are also driving growth in the enteric disease testing market. Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are investing in programs to improve access to diagnostics, strengthen disease surveillance systems, and enhance the capacity for rapid response to outbreaks. These efforts are increasing the demand for advanced enteric disease testing solutions that can support these goals.

Additionally, the focus on antimicrobial resistance (AMR) is influencing the enteric disease testing market. With the growing concern over the misuse of antibiotics and the rise of resistant pathogens, there is an increasing emphasis on accurate diagnosis to ensure appropriate treatment. Enteric disease testing that can rapidly identify the causative pathogen and its resistance profile is becoming essential in the fight against AMR.

These trends highlight the critical role of enteric disease testing in improving public health, enhancing disease management, and responding to the challenges posed by infectious diseases. As the market continues to evolve, innovations in testing technology and global health initiatives will likely drive further growth and development, ensuring that enteric disease testing remains a vital component of healthcare worldwide.

Select Competitors (Total 12 Featured) -

  • Apollo Diagnostics
  • bioMerieux Sweden AB
  • Centre for Infectious Disease Research in Zambia (CIDRZ)
  • EntroGen, Inc.
  • Genovate Laboratories Inc.
  • Quest Diagnostics, Inc.
  • TECHLAB, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Enteric Disease Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Global Prevalence of Enteric Diseases Spurs Demand for Rapid Diagnostic Tests
    • Growing Travel and Migration Contributing to Spread of Enteric Pathogens
    • Integration of Point-of-Care Testing Devices in Remote and Resource-Limited Settings
    • Rising Healthcare Infrastructure Investments in Emerging Economies
    • Market Trends Towards Multiplexed Testing Platforms for Simultaneous Detection
    • Future Trends: AI and Machine Learning Integration in Diagnostic Processes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bacterial Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Bacterial Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Viral Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Viral Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Parasitic Enteric Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Parasitic Enteric Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Conventional Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Conventional Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Molecular Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Molecular Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Enteric Disease Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Enteric Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • JAPAN
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • CHINA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • EUROPE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Enteric Disease Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • GERMANY
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Enteric Disease Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • AUSTRALIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • INDIA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Enteric Disease Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Enteric Disease Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Enteric Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030
  • AFRICA
    • Enteric Disease Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Enteric Disease Testing by Disease Indication - Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Enteric Disease Testing by Disease Indication - Percentage Breakdown of Value Sales for Bacterial Enteric Disease, Parasitic Enteric Disease and Viral Enteric Disease for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Enteric Disease Testing by Testing Method - Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Enteric Disease Testing by Testing Method - Percentage Breakdown of Value Sales for Conventional Testing, Molecular Diagnostic Testing and Other Testing Methods for the Years 2014, 2024 & 2030

IV. COMPETITION